Search

Financial Highlights

  In Rupiah billion In SGD million*
  2013 Actual
2014 Actual 2015 Actual 2013 Actual
2014 Actual 2015 Actual
Net Sales 13,280 14,963 13,835 1,360 1,533 1,417
Gross Profit 3,204 4,368 3,350 328 447 343
Gain/(Loss) Arising from Changes in
Fair Values of Biological Assets
62 60 (20) 6 6 (2)
Operating Income 1,692 2,536 1,251 173 260 128
Net Profit 921 1,328 299 94 136 31
Attributable Profit to Equity Holders 523 759 58 54 78 6
EPS (in Rupiah)/(in SGD 'cents) 366 535 41 3.7 5.5 0.4
Current Assets 6,938 6,812 5,375 712 699 551
Fixed Assets 23,674 26,087 27,375 2,428 2,675 2,807
Other Assets 7,093 7,255 7,970 727 744 817
Total Assets 37,705 40,155 40,720 3,867 4,118 4,176
Current Liabilities 6,504 6,951 6,451 667 713 662
Non-Current Liabilities 8,367 9,486 10,023 858 973 1,028
Total Liabilities 14,872 16,437 16,474 1,525 1,686 1,689
Shareholders' Equity 13,996 14,629 14,390 1,435 1,500 1,476
Total Equity 22,833 23,717 24,246 2,342 2,432 2,486
 
In Percentage (%)
Sales Growth (4.1%) 12.7% (7.5%)  
Gross Profit Margin 24.1% 29.2% 24.2%
Operating Profit Margin 12.7% 17.0% 9.0%
Net Profit Margin 6.9% 8.9% 2.2%
Attributable Profit to Equity Holders Margin 3.9% 5.1% 0.4%
Return on Assets1 4.5% 6.3% 3.1%
Return on Equity2 3.7% 5.2% 0.4%
Current Ratio (times) 1.1 1.0 0.8
Net Debt to Equity Ratio (times)3 0.22 0.26 0.34
Total Debt to Total Assets Ratio (times) 0.23 0.24 0.25

1 Profit from operations divided by total assets
2 Net profit to equity holders divided by shareholders' equity
3 Net debt divided by total equity

* For ease of reference, 2013 to 2015 Income Statement and Balance Sheet items are converted at exchange rates of Rp9,763/S$1 and Rp9,751/S$1, respectively.

Investor Relations